Does initial hydromorphone relieve pain best if dosing is fixed or weight based?

Area of Science:

• Emergency Medicine
• Pharmacology
• Pain Management

Background:

• Optimal initial opioid dosing strategies, whether fixed or weight-based, remain unclear for acute pain.
• Intravenous hydromorphone is frequently used for acute pain management in emergency departments.

Purpose of the Study:

• To investigate if pain response to a fixed dose of intravenous hydromorphone differs based on total body weight.
• To compare fixed versus weight-based dosing for initial opioid administration in adults with acute pain.

Main Methods:

• A convenience sample of 163 adults (18-65 years) with acute pain received 1 mg of intravenous hydromorphone.
• Pain reduction was measured using a numeric rating scale at 30 minutes.
• Multivariate analysis controlled for variables influencing pain response and body weight.

Main Results:

• Pain reduction at 30 minutes did not correlate with total body weight in univariate or multivariable analyses.
• No significant differences were observed in secondary efficacy measures (pain relief, satisfaction) based on weight.
• Lower-weight subjects reported greater pruritus, but other adverse events were similar across weight groups.

Conclusions:

• A fixed 1 mg intravenous hydromorphone dose demonstrated comparable pain relief across a range of adult body weights.
• These findings suggest that fixed opioid dosing may be a viable alternative to weight-based dosing for initial hydromorphone administration.
• Further research could explore optimal fixed doses for diverse patient populations and pain types.